Funding for this research was provided by:
Nippon Boehringer Ingelheim Co., Ltd.
Article History
First Online: 3 August 2019
Compliance with Ethical Standards
:
: Financial support for the development of this manuscript was provided by Nippon Boehringer Ingelheim.
: TI received honoraria from Kyorin Pharmaceutical; received research funding from Nippon Boehringer Ingelheim, Teijin Pharma, Astellas Pharma, Meiji Seika Pharma and Kyorin Pharmaceutical. YT held an advisory role for Kyorin Pharmaceutical and Meiji Seika Pharma; received honoraria from Teijin Pharma, AstraZeneca, Kyorin Pharmaceutical, Torii Pharmaceutical, Nippon Boehringer Ingelheim, Novartis Pharma and Daiichi Sankyo; received research funding from Daiichi Sankyo, Teijin Pharma, Astellas Pharma, Nippon Boehringer Ingelheim, Ono Pharmaceutical, Taiho Pharmaceutical and Taisho Toyama Pharmaceutical. SN and YS are employees of Nippon Boehringer Ingelheim Co., Ltd.